AU6582696A – Process for preparing intermediates for thrombin inhibitors
– Google Patents
AU6582696A – Process for preparing intermediates for thrombin inhibitors
– Google Patents
Process for preparing intermediates for thrombin inhibitors
Info
Publication number
AU6582696A
AU6582696A
AU65826/96A
AU6582696A
AU6582696A
AU 6582696 A
AU6582696 A
AU 6582696A
AU 65826/96 A
AU65826/96 A
AU 65826/96A
AU 6582696 A
AU6582696 A
AU 6582696A
AU 6582696 A
AU6582696 A
AU 6582696A
Authority
AU
Australia
Prior art keywords
thrombin inhibitors
preparing intermediates
intermediates
preparing
thrombin
Prior art date
1995-05-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65826/96A
Inventor
David R. Kronenthal
Sharon D. Real
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1995-05-18
Filing date
1996-09-24
Publication date
1998-03-26
1995-05-18
Priority to US08/443,960
priority
Critical
patent/US5610308A/en
1996-09-19
Priority to CA002185950A
priority
patent/CA2185950A1/en
1996-09-24
Application filed by Bristol Myers Squibb Co
filed
Critical
Bristol Myers Squibb Co
1996-09-24
Priority to AU65826/96A
priority
patent/AU6582696A/en
1996-09-27
Priority to EP96307111A
priority
patent/EP0832879A1/en
1996-10-02
Priority to JP8261651A
priority
patent/JPH10114741A/en
1998-03-26
Publication of AU6582696A
publication
Critical
patent/AU6582696A/en
Status
Abandoned
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P25/00—Drugs for disorders of the nervous system
A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer’s disease or other forms of dementia
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P31/04—Antibacterial agents
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P7/00—Drugs for disorders of the blood or the extracellular fluid
A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P9/00—Drugs for disorders of the cardiovascular system
A61P9/08—Vasodilators for multiple indications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P9/00—Drugs for disorders of the cardiovascular system
A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07K—PEPTIDES
C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
C07K5/06—Dipeptides
C07K5/06008—Dipeptides with the first amino acid being neutral
C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K38/00—Medicinal preparations containing peptides
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
Y02P20/00—Technologies relating to chemical industry
Y02P20/50—Improvements relating to the production of bulk chemicals
Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
AU65826/96A
1995-05-18
1996-09-24
Process for preparing intermediates for thrombin inhibitors
Abandoned
AU6582696A
(en)
Priority Applications (5)
Application Number
Priority Date
Filing Date
Title
US08/443,960
US5610308A
(en)
1995-05-18
1995-05-18
Process for preparing intermediates for thrombin inhibitors
CA002185950A
CA2185950A1
(en)
1995-05-18
1996-09-19
Process for preparing intermediates for thrombin inhibitors
AU65826/96A
AU6582696A
(en)
1995-05-18
1996-09-24
Process for preparing intermediates for thrombin inhibitors
EP96307111A
EP0832879A1
(en)
1995-05-18
1996-09-27
Process for preparing intermediates for thrombin inhibitors
JP8261651A
JPH10114741A
(en)
1995-05-18
1996-10-02
Production of intermediate for thrombin inhibitor
Applications Claiming Priority (5)
Application Number
Priority Date
Filing Date
Title
US08/443,960
US5610308A
(en)
1995-05-18
1995-05-18
Process for preparing intermediates for thrombin inhibitors
CA002185950A
CA2185950A1
(en)
1995-05-18
1996-09-19
Process for preparing intermediates for thrombin inhibitors
AU65826/96A
AU6582696A
(en)
1995-05-18
1996-09-24
Process for preparing intermediates for thrombin inhibitors
EP96307111A
EP0832879A1
(en)
1995-05-18
1996-09-27
Process for preparing intermediates for thrombin inhibitors
JP8261651A
JPH10114741A
(en)
1995-05-18
1996-10-02
Production of intermediate for thrombin inhibitor
Publications (1)
Publication Number
Publication Date
AU6582696A
true
AU6582696A
(en)
1998-03-26
Family
ID=27507169
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU65826/96A
Abandoned
AU6582696A
(en)
1995-05-18
1996-09-24
Process for preparing intermediates for thrombin inhibitors
Country Status (5)
Country
Link
US
(1)
US5610308A
(en)
EP
(1)
EP0832879A1
(en)
JP
(1)
JPH10114741A
(en)
AU
(1)
AU6582696A
(en)
CA
(1)
CA2185950A1
(en)
Families Citing this family (5)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
NZ513217A
(en)
*
1999-03-11
2003-11-28
Du Pont Pharm Co
Treatment of thrombosis by combined use of a factor Xa inhibitor and aspirin, tissue plasminogen activator (TPA), a GPIIb/IIIa antagonist, low molecular weight heparin or heparin
US6794412B1
(en)
1999-03-11
2004-09-21
Bristol-Myers Squibb Pharma Company
Treatment of thrombosis by combined use of a factor Xa inhibitor and aspirin
US20030045449A1
(en)
*
2001-08-15
2003-03-06
Pfizer, Inc.
Pharmaceutical combinations for the treatment of neurodegenerative diseases
US9555016B2
(en)
2013-06-10
2017-01-31
Covidien Lp
Lytic agents for use in treating intravascular clots
CN109503887A
(en)
*
2017-09-14
2019-03-22
衢州市中通化工有限公司
A kind of preparation method of silane fire retardant
Family Cites Families (5)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
TW223629B
(en)
*
1992-03-06
1994-05-11
Hoffmann La Roche
AU675981B2
(en)
*
1992-12-02
1997-02-27
Bristol-Myers Squibb Company
Guanidinyl-substituted heterocyclic thrombin inhibitors
SE9301916D0
(en)
*
1993-06-03
1993-06-03
Ab Astra
NEW PEPTIDES DERIVATIVES
SE9301912D0
(en)
*
1993-06-03
1993-06-03
Ab Astra
PROCESS FOR THE PRODUCTION OF AMINOALKYLGUANDINES
US5498724A
(en)
*
1994-06-28
1996-03-12
Aktiebolaget Astra
Pyrazoleamidine compounds
1995
1995-05-18
US
US08/443,960
patent/US5610308A/en
not_active
Expired – Lifetime
1996
1996-09-19
CA
CA002185950A
patent/CA2185950A1/en
not_active
Abandoned
1996-09-24
AU
AU65826/96A
patent/AU6582696A/en
not_active
Abandoned
1996-09-27
EP
EP96307111A
patent/EP0832879A1/en
not_active
Withdrawn
1996-10-02
JP
JP8261651A
patent/JPH10114741A/en
active
Pending
Also Published As
Publication number
Publication date
CA2185950A1
(en)
1998-03-20
US5610308A
(en)
1997-03-11
JPH10114741A
(en)
1998-05-06
EP0832879A1
(en)
1998-04-01
Similar Documents
Publication
Publication Date
Title
AU4875196A
(en)
1996-09-04
Novel thrombin inhibitors
AU4698396A
(en)
1996-08-21
Process for modifying surfaces
AU1301697A
(en)
1997-07-17
Tyrosin-derivate as alpha-v-integrin inhibitors
AU4269896A
(en)
1996-07-19
Fibronectin adhesion inhibitors
AU4787596A
(en)
1996-08-27
Thrombin inhibitors
AU7497596A
(en)
1997-05-29
Thrombin inhibitors
AU4838996A
(en)
1996-10-02
Process for tetraazacycloalkane preparation
AU7034896A
(en)
1997-05-08
Process for preparing nicotinamide
AU3661797A
(en)
1998-02-10
Method for activation of bleaches
AU6043096A
(en)
1996-12-24
Methods for minimizing bone loss
AU7577396A
(en)
1997-06-05
New preparation process for phenylimidazolidine derivatives
AU6488796A
(en)
1997-02-10
Process for preparing quinoline bases
AU2277597A
(en)
1997-09-10
New inhibitors of sh2-mediated processes
AU6018798A
(en)
1998-08-03
Method for enhanced plant productivity
AU1149797A
(en)
1997-07-03
Naphthyl glyoxamides as spla2 inhibitors
AU3126495A
(en)
1996-02-22
Process for making alkyl polyglycosides
AU2925897A
(en)
1997-11-19
Method for manufacture of small dimension product
AU4195797A
(en)
1998-04-14
Process for producing simvastatin
AU6582696A
(en)
1998-03-26
Process for preparing intermediates for thrombin inhibitors
AU6131098A
(en)
1998-08-03
Method for enhanced plant productivity
AU5746296A
(en)
1996-11-29
Process for making hiv protease inhibitors
AU6049796A
(en)
1996-12-30
Lysyloxidase inhibitors
AU4958397A
(en)
1998-07-17
Process for making benzisothiazolin-3-ones
AU7562996A
(en)
1997-06-19
Process for preparing dioxoazabicyclohexanes
AU7476296A
(en)
1997-05-15
Novel subtilisin inhibitors
None